Longeveron is a regenerative medicine company developing innovative cell-based therapies for aging-related chronic and life-threatening diseases. The firm is organized around research that support stheir offering Longeveron-grown Mesenchymal Stem Cells, the multipotent stem cells used for medical conditions such as aging frailty, alzheimers, and metabolic syndrome, The company is focused on the development of allogeneic (donor-derived) human mesenchymal stem cells (MSCs) - a product derived from the bone marrow of young, healthy adult donors - that are harvested and grown at the firm's manufacturing facility. In addition to manufacturing its own cells in this cGMP facility, Longeveron is also conducting clinical trials and manufacturing cells for other parties through its cell therapy CMO business.
